Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
Breccia
Massimo
M
Latagliata
Roberto
R
Carmosino
Ida
I
Cannella
Laura
L
Diverio
Daniela
D
Guarini
Anna
A
De Propris
Maria Stefania
MS
Petti
Maria Concetta
MC
Avvisati
Giuseppe
G
Cimino
Giuseppe
G
Mandelli
Franco
F
Lo-Coco
Francesco
F
D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use*; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000188:drug therapy*; D013577:Syndrome; D016896:Treatment Outcome; D014212:Tretinoin / Q000009:adverse effects* / Q000627:therapeutic use
D014212:Tretinoin; D015255:Idarubicin